CellOrigin Biotech Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Early Stage VC
- Investors
-
8
CellOrigin Biotech General Information
Description
Developer of immune cell therapies designed for the treatment of solid tumors and hematological malignancies. The company utilizes single-cell sequencing, synthetic biology, and gene editing to develop chimeric antigen receptor macrophages and natural killer cells, enabling healthcare providers to access off-the-shelf allogeneic treatments that infiltrate the tumor microenvironment.
Contact Information
Website
www.cell-origin.comCorporate Office
- Room 201 East, Building 4, Number 110 Liuze Street, Cangqian Subdistrict
- Yuhang District
- Hangzhou, Zhejiang 311121
- China
Corporate Office
- Room 201 East, Building 4, Number 110 Liuze Street, Cangqian Subdistrict
- Yuhang District
- Hangzhou, Zhejiang 311121
- China
CellOrigin Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 20-Sep-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 16-Feb-2022 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 16-Jul-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 06-Feb-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 28-Apr-2019 | Completed | Startup |
CellOrigin Biotech Signals
CellOrigin Biotech Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Goldport Capital | Venture Capital | Minority | ||
| Hangzhou Yuhang State-owned Capital Investment and Operation Group | Government | Minority | ||
| Jifeng Ventures | Venture Capital | Minority | ||
| Shenzhen Yifeng Investment Management Enterprise | Venture Capital | Minority | ||
| Yinxinggu Capital | Venture Capital | Minority |
CellOrigin Biotech FAQs
-
When was CellOrigin Biotech founded?
CellOrigin Biotech was founded in 2018.
-
Where is CellOrigin Biotech headquartered?
CellOrigin Biotech is headquartered in Hangzhou, China.
-
What is the size of CellOrigin Biotech?
CellOrigin Biotech has 1 total employees.
-
What industry is CellOrigin Biotech in?
CellOrigin Biotech’s primary industry is Drug Discovery.
-
Is CellOrigin Biotech a private or public company?
CellOrigin Biotech is a Private company.
-
What is CellOrigin Biotech’s current revenue?
The current revenue for CellOrigin Biotech is .
-
How much funding has CellOrigin Biotech raised over time?
CellOrigin Biotech has raised $15.7M.
-
Who are CellOrigin Biotech’s investors?
Goldport Capital, Hangzhou Yuhang State-owned Capital Investment and Operation Group, Jifeng Ventures, Shenzhen Yifeng Investment Management Enterprise, and Yinxinggu Capital are 5 of 8 investors who have invested in CellOrigin Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process